š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The primary objective of this study is the estimation of the human papillom...
Status
Completed
Location
Sotobo Children's Clinic ( Site 6616)
Start Date
2021-05-17
Trial ID
NCT04772534
Treatments Being Tested
This study will evaluate the efficacy, immunogenicity and safety of 9-valen...
Status
Active Not Recruiting
Location
Lingchuan Center for Disease Control and Prevention ( Site 0002)
Start Date
2019-06-26
Trial ID
NCT03998254
This is a non-randomized, open label study to assess the reduction of Human...
Status
Recruiting
Location
Gynaecology Unit, Bellvitge University Hospital (HUB)
Start Date
2022-09-13
Trial ID
NCT05334706
Treatments Being Tested
Since the 2019-2020 school year, the province of Quebec (Canada) has been a...
Status
Recruiting
Location
Centre de recherche du CHU de QuƩbec-UniversitƩ Laval
Start Date
2025-09-23
Trial ID
NCT07156084
Treatments Being Tested
Primary objective: ā¢ To demonstrate that administration of V503 induces no...
Status
Completed
Location
Multiple Locations
Start Date
2011-02-23
Trial ID
NCT01304498
Cervical cancer is one of the most common cancer in women, making it the fo...
Status
Unknown
Location
Cancer Prevention Center,Sun Yat-sen University Cancer Cente
Start Date
2023-05-04
Trial ID
NCT05838157
Treatments Being Tested
The study will evaluate the immunogenicity and safety of 9-valent HPV recom...
Status
Completed
Location
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Start Date
2020-09-19
Trial ID
NCT05372016
This is a multi-site, open-label non-inferiority study of the 9vHPV vaccine...
Status
Completed
Location
AHF Lamvelase
Start Date
2022-04-01
Trial ID
NCT04982614
Treatments Being Tested
This study will evaluate the safety and immunogenicity of V503 (GARDASILā¢9,...
Status
Completed
Location
National Institute of Hygiene and Epidemiology ( Site 0001)
Start Date
2018-06-29
Trial ID
NCT03546842
Treatments Being Tested
This study is designed to demonstrate non-inferior immunogenicity of 3 dose...
Status
Active Not Recruiting
Location
Liucheng County Centers for Disease Control and Prevention ( Site 0005)
Start Date
2022-05-07
Trial ID
NCT05314023
Treatments Being Tested